Previous 10 |
home / stock / neon:cc / neon:cc news
Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002 OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) (" NeonMind '' or the " Company "), an integ...
OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. ( CSE:NEON )( OTCQB:NMDBF )( FRA:6UF ) (" NeonMind '' or the " Company "), an integrated drug development and wellness company focused on bringing innovative psychedelic-based treatments to people suffering from obesity a...
News, Short Squeeze, Breakout and More Instantly...
Neonmind Biosciences Inc Company Name:
NEON:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - le 13 juin/June 2023) - The common shares of Lancaster Resources Inc. (LCR) previously listed as NeonMind Biosciences Inc. (NEON) have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading...
Overview Psychedelics have taken center stage as an emerging treatment for mental health and behavioral disorders. Major research institutes such as John Hopkins and biotechnology companies have generated promising clinical data on the efficacy and safety of treatm...
Engages Thrive Health, a Leading Digital Patient Care Platform to Streamline Care Programs and Data Collection OAKVILLE, ON / ACCESSWIRE / April 21, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF) (" NeonMind '' or the " Company "), announced today it has advanced it...